Plasma protease C1-inhibitor treatments play a critical role in managing hereditary angioedema (HAE) by regulating complement system overactivation and preventing life-threatening swelling episodes. These products, derived from human plasma or produced via recombinant DNA technology, offer rapid symptom relief and long-term prophylactic benefits. Advantages include high bioavailabilit... https://www.patreon.com/posts/plasma-protease-129505439